Up To 50 SAR OFF Your First Order Use Code : APP50 | Get Free Delivery With No Minimum Order

Frequently bought together
RUMAFEN 50/MG TAB 20/TAB
- Sku : I-005661
Key features
RUMAFEN 50 mg coated tablet is a prescription NSAID containing diclofenac sodium 50 mg per tablet. It inhibits cyclooxygenase (COX‑1 and COX‑2), reducing prostaglandin synthesis to alleviate inflammation, pain and fever. It is indicated for symptomatic treatment of pain and inflammation in rheumatic conditions such as rheumatoid arthritis, osteoarthritis and ankylosing spondylitis, and for acute pain including primary dysmenorrhea. Supplied as coated tablets in a pack of 20 (prescription only).- Brand: RUMAFEN
- Active Ingredient: DICLOFENAC SODIUM
- Strength: 50mg
- Dosage Form: Coated tablet
- Pack Size: 20 Tablets
- Route: Oral use
- Prescription Status: Prescription
- Therapeutic Class: Musculoskeletal
- Pharmacological Group: Topical Joint & Muscle Products
- Drug Class: Nonsteroidal anti-inflammatory drug (NSAID); nonselective COX inhibitor; acetic acid (phenylacetic acid) derivative.
- Manufacturer: RIYADH PHARMA
- Country of Origin: Saudi Arabia
- SFDA Registration No.: 1405245285
- Shelf Life: 36 months
- Storage: store below 25°c
- Pain Type: Muscular, Joint, General
- Nsaid: Yes
- Opioid: No
Frequently bought together
Indications
Approved Uses
Symptomatic treatment of pain and inflammation in rheumatic conditions (e.g., rheumatoid arthritis, osteoarthritis, ankylosing spondylitis) and acute pain conditions such as primary dysmenorrhea.
Dosage & Administration
Dosing by Condition
Adults (delayed-release diclofenac sodium): Osteoarthritis: 100-150 mg/day in divided doses (50 mg 2-3 times daily or 75 mg twice daily). Rheumatoid arthritis: 150-200 mg/day in divided doses (50 mg 3-4 times daily or 75 mg twice daily). Ankylosing spondylitis: 100-125 mg/day (25 mg 4 times daily, plus 25 mg at bedtime if needed)
Initial Dose
50mg two to three times daily for osteoarthritis or rheumatoid arthritis.
Maintenance Dose
For osteoarthritis: 100-150 mg/day in divided doses (50 mg 2-3 times daily or 75 mg twice daily); For rheumatoid arthritis: 150-200 mg/day in divided doses (50 mg 3-4 times daily or 75 mg twice daily); For ankylosing spondylitis: 100-125 mg/day (25 mg 4 times daily, plus 25 mg at bedtime if needed)
Maximum Dose
Maximum total daily dose (immediate-release oral diclofenac sodium): 150 mg/day.
Dose Adjustment Notes
Use the lowest effective dose for the shortest duration; use caution and consider lower starting doses in the elderly; avoid in severe/advanced renal disease and in severe hepatic impairment; monitor and adjust based on tolerability and renal/hepatic function.
How to Take
Swallow the coated tablet whole with water; take with or immediately after food (or milk) to reduce gastrointestinal irritation; do not crush or chew.
Side Effects
Common Side Effects
Dyspepsia, abdominal pain, nausea, diarrhea (sometimes constipation), headache, dizziness; rash/pruritus and edema can occur; liver enzyme elevations may occur.
Safety & Warnings
Contraindications
Contraindications: Hypersensitivity to diclofenac or other NSAIDs; history of asthma/urticaria/other allergic-type reactions after aspirin/NSAIDs (AERD); use in the setting of CABG surgery; active GI bleeding or active peptic ulcer. Avoid/contraindicated in late pregnancy (3rd trimester).
Warnings & Precautions
Key warnings/precautions: CV thrombotic risk (use lowest effective dose/shortest duration; caution in CVD risk); contraindicated with CABG; GI bleeding/ulcer risk (higher in elderly, prior PUD/GI bleed; consider gastroprotection when indicated); renal toxicity/AKI risk (caution with CKD, dehydration, ACEi/ARB+diuretic); hepatotoxicity (check/monitor LFTs; stop if persistent elevation/symptoms); fluid retention/HTN/HF worsening (monitor BP/edema); severe hypersensitivity and serious skin reactions; avoid in AERD; avoid in late pregnancy.
Drug Interactions
Food Interaction
Take with food
Special Populations
Pregnancy
Avoid in third trimester; use in first and second trimesters only if benefit outweighs risk (FDA Pregnancy Category C first/second trimester, D third trimester)
Elderly
Use lowest effective dose (start with 50mg twice daily), monitor renal function, blood pressure, and GI tolerance closely; increased risk of adverse effects
Storage & Patient Advice
Stopping the Medicine
Safe to stop anytime; no tapering required for short-term use. For long-term use, consult prescriber before stopping
Overdose
Overdose: symptoms may include nausea/vomiting, epigastric pain, GI bleeding, dizziness/drowsiness, headache, tinnitus; severe cases may cause hypotension, acute kidney injury, metabolic acidosis, respiratory depression, seizures/coma. Management: supportive care; consider activated charcoal if recent ingestion; monitor renal/hepatic function and GI bleeding; no specific antidote.
Patient Counseling
Take with or after food and swallow whole; do not exceed the prescribed dose (usual max 150 mg/day). Avoid combining with other NSAIDs/aspirin unless directed. Limit/avoid alcohol. Seek urgent care for GI bleeding (black stools/vomiting blood), severe abdominal pain, allergic reactions, or cardiovascular symptoms (chest pain, shortness of breath, sudden weakness). Inform clinician about pregnancy (avoid in 3rd trimester) and about anticoagulants, lithium, methotrexate, and kidney/liver disease. Store below 25°C.
Monitoring Requirements
If used beyond short courses: monitor blood pressure, renal function (SCr/eGFR), hepatic transaminases, and CBC periodically; assess for GI bleeding/ulceration and cardiovascular risk throughout therapy.
Pharmacology
Mechanism of Action
Inhibits cyclooxygenase (COX-1 and COX-2), decreasing prostaglandin synthesis and thereby reducing inflammation, pain, and fever.
Bioavailability
Approximately 50% systemic bioavailability due to first-pass metabolism (often cited ~50-60%).
Metabolism
Extensive first-pass hepatic metabolism; primarily metabolized to 4'-hydroxy-diclofenac via CYP2C9 (major), with minor contributions from CYP2C8 and CYP3A4; metabolites undergo glucuronidation.
Protein Binding
>99% protein bound (mainly to albumin).
Product Information
Available Dosage Forms
For this product: oral coated tablet 50 mg (blister pack of 20).
Composition per Dose
Each coated tablet: 50mg diclofenac sodium
Generic Availability
Yes
Pain Type
Muscular, Joint, General
Nsaid
Yes
Opioid
No
Legal Disclaimer - Al Mujtama Pharmacy
The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.
Al Mujtama Pharmacy assumes no legal or medical liability for:
- Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
- Any discrepancy between the information provided and the product's package insert or SFDA guidelines
- Any misuse of medication resulting from personal interpretation of the content displayed
Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.
By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.
Your health is a trust - always consult your doctor first.
-1744229570.gif)














